γδ T cells in combination with Newcastle disease virus and dendritic cell therapy as a novel immunotherapeutic approach in treating of advanced lung cancer.

Association of increased progression-free survival in primary glioblastomas with lymphopenia at baseline and activation of NK and NKT cells after dendritic cell immunotherapy.

Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.

A feasibility and safety study of vaccination with poly-ICLC and peptide-pulsed dendritic cells in patients with metastatic, locally advanced unresectable, or recurrent pancreatic adenocarcinoma.

Dendritic cell immunotherapy for glioblastoma

Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective

Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells

Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer

Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies